Your browser doesn't support javascript.
loading
Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis.
Dimopoulos, Meletios A; Leleu, Xavier; Moreau, Philippe; Richardson, Paul G; Liberati, Anna Marina; Harrison, Simon J; Miles Prince, H; Ocio, Enrique M; Assadourian, Sylvie; Campana, Frank; Malinge, Laure; Sémiond, Dorothée; van de Velde, Helgi; Yong, Kwee.
Afiliação
  • Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece. mdimop@med.uoa.gr.
  • Leleu X; Department of Hematology, Centre Hospitalier Universitaire, Université de Poitiers, Poitiers, France.
  • Moreau P; University of Nantes, Nantes, France.
  • Richardson PG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Liberati AM; Oncology-Hematology, Santa Maria Hospital, University of Perugia, Terni, Italy.
  • Harrison SJ; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Miles Prince H; Epworth Healthcare, University of Melbourne, Melbourne, VIC, Australia.
  • Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.
  • Assadourian S; Sanofi R&D, Paris, France.
  • Campana F; Sanofi-Genzyme Oncology, Cambridge, MA, USA.
  • Malinge L; Aixial (for Sanofi), Boulogne-Billancourt, France.
  • Sémiond D; Sanofi R&D, Paris, France.
  • van de Velde H; Sanofi-Genzyme Oncology, Cambridge, MA, USA.
  • Yong K; Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Leukemia ; 35(2): 562-572, 2021 02.
Article em En | MEDLINE | ID: mdl-32444867
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Insuficiência Renal / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Insuficiência Renal / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article